WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997010850) TRANSCYTOSIS VEHICLES AND ENHANCERS FOR DRUG DELIVERY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/010850    International Application No.:    PCT/GB1996/002326
Publication Date: 27.03.1997 International Filing Date: 20.09.1996
Chapter 2 Demand Filed:    24.03.1997    
IPC:
A61K 38/00 (2006.01), A61K 47/48 (2006.01), C07K 14/705 (2006.01)
Applicants: ANDARIS LIMITED [GB/GB]; 1 Mere Way, Ruddington, Nottingham NG11 6JS (GB) (For All Designated States Except US).
SUTTON, Andrew, Derek [GB/GB]; (GB) (For US Only).
MALIK, Asrar, Bari [US/US]; (US) (For US Only).
TIRUPPATHI, Chinnaswamy [US/US]; (US) (For US Only).
JOHNSON, Richard, Alan [GB/GB]; (GB) (For US Only)
Inventors: SUTTON, Andrew, Derek; (GB).
MALIK, Asrar, Bari; (US).
TIRUPPATHI, Chinnaswamy; (US).
JOHNSON, Richard, Alan; (GB)
Agent: GILL JENNINGS & EVERY; Broadgate House, 7 Eldon Street, London EC2M 7LH (GB)
Priority Data:
60/004,097 21.09.1995 US
9606315.1 26.03.1996 GB
Title (EN) TRANSCYTOSIS VEHICLES AND ENHANCERS FOR DRUG DELIVERY
(FR) VEHICULES ET STIMULATEURS DE TRANSCYTOSE POUR L'ADMINISTRATION DE MEDICAMENTS
Abstract: front page image
(EN)Transcytosis of a physiologically-active agent that exerts its action following passage across endothelia, epithelia or mesothelia containing the GP60 receptor, is enhanced by formulation with or conjugation to a transcytosis enhancer or vehicle selected from albumin and fragments thereof, anti-GP60 antibody and fragments thereof, GP60 peptide fragments, and PDI (protein disulphide isomerase) and fragments thereof.
(FR)La transcytose d'un agent physiologiquement actif exerçant son action après passage à travers l'endothélium, l'épithélium ou le mésothélium contenant le récepteur GP60, est stimulée par la formulation ou par la conjugaison d'un stimulateur ou d'un véhicule de transcytose sélectionné à partir d'albumine ou de fragments d'albumine, d'un anticorps anti-GP60 et de fragments de cet anticorps, de fragments de peptide GP60, ainsi que de protéine disulfure isomérase (PDI) et de fragments de PDI.
Designated States: AL, AM, AU, AZ, BA, BB, BG, BR, BY, CA, CN, CU, CZ, EE, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, RO, RU, SD, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)